Literature DB >> 3076399

Puzzling diabetic transgenic mice: a lesson for human type 1 diabetes?

R Pujol-Borrell, G F Bottazzo.   

Abstract

Entities:  

Mesh：

Year:  1988        PMID： 3076399     DOI： 10.1016/0167-5699(88)91322-9

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


× No keyword cloud information.
  6 in total

1.  Beta cell expression of endogenous xenotropic retrovirus distinguishes diabetes-susceptible NOD/Lt from resistant NON/Lt mice.

Authors:  H R Gaskins; M Prochazka; K Hamaguchi; D V Serreze; E H Leiter
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

Review 2.  I-E transgenic mice: a model system to dissect the regulation and function of MHC class II genes in vivo.

Authors:  L C Burkly; D Lo; R L Brinster; R A Flavell
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

3.  Peripheral tolerance to allogeneic class II histocompatibility antigens expressed in transgenic mice: evidence against a clonal-deletion mechanism.

Authors:  K M Murphy; C T Weaver; M Elish; P M Allen; D Y Loh
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

4.  Genetic and Pharmacologic Models for Type 1 Diabetes.

Authors:  Edward H Leiter; Andrew Schile
Journal:  Curr Protoc Mouse Biol       Date:  2013-03-01

5.  Intercellular adhesion molecule-1 (ICAM-1) in Graves' disease: contrast between in vivo and in vitro results.

Authors:  A Ciampolillo; G Napolitano; R Mirakian; A Miyasaki; R Giorgino; G F Bottazzo
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

6.  MHC antigen induction by interferon gamma on cultured mouse pancreatic beta cells and macrophages. Genetic analysis of strain differences and discovery of an "occult" class I-like antigen in NOD/Lt mice.

Authors:  E H Leiter; G J Christianson; D V Serreze; A T Ting; S M Worthen
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.